Endocrine Abstracts

Background: PYY is a gut hormone that physiologically inhibits appetite. Currently only radioimmunoassay (RIA) techniques are available for its estimation. The aim of the study was to evaluate our in-house assay for precision, detection limit, interference of haemolysis, suitability of serum versus plasma and biological variation within one subject.Method: All samples were obtained from one subject on two occasions following an over night fast and the co...

BACKGROUND: The reason for reduction in appetite following gastro intestinal bypass procedures in man and in animal models remains unclear. Rats following jejunum intestinal bypass eat significantly less compared to sham operated rats and this seem due to a transferable factor in plasma. Such a humoral factor may be a therapeutic option for obesity. PYY, produced from the distal small bowel and colon is elevated in man and rodents following small bowel resection and ilial bypa...

Background: Changes in gut hormone levels after laparoscopic sleeve gastrectomy (LSG) has been proposed as a possible mechanism that explains the long-term weight loss and the improvement in glucose homeostasis after bariatric operations. In this prospective study we evaluated the changes in the fasting and postprandial levels of glucagon like peptide-1 (GLP-1), peptide YY (PYY), insulin and glucose during the first postoperative year after LSG.Methods: ...

BackgroundThe gut hormone peptide YY (PYY) is released postprandially acting as a satiety signal. Obese adults have reduced concentrations of PYY in the fasting and postprandial state. Animal data suggest that lower PYY levels are likely to be a consequence rather than a cause of obesity. We aimed to investigate PYY in the fasting state and after a 420 kcal meal in post pubertal children.MethodNine normal wei...

ObjectiveBariatric surgery has an important role in the management of morbidly obese patients. Roux-en-Y gastric bypass (RYGB) is an established bariatric procedure. In this study, we aimed to investigate prospective changes in the entero-hypothalamic endocrine axis following RYGB, examining the meal-stimulated responses of peptide-YY (PYY), glucagon-like peptide 1 (GLP-1) and ghrelin.MethodsSix female patien...

Background: Obese subjects are usually in a positive energy balance despite their best efforts to lose weight. This study aimed to determine if hunger, nausea and satiety levels differ in lean and obese subjects after consuming varying calorific meals.Method: Following an overnight fast, test meals of 250, 500, 1000, 2000 and 3000 kcal were consumed by 19 lean and 19 obese subjects. Hunger, nausea and satiety levels were measured using visual analogue sc...

Background: The gut hormone PYY3-36 (PYY) is released into the circulation after eating and physiologically inhibits food intake. Obese and lean subjects are equally sensitive to this effect, however fasting levels of PYY are reduced in obese subjects.Methods: We investigated the postprandial PYY response and satiety response using a visual analogue scale (VAS) to 6 test meals of increasing calorie content in 20 lean and 20 obese subjects. We also infuse...

Most tests of the hypothalamo-pituitary-adrenal axis (HPA) use total cortisol measurements, although only free cortisol is biologically active. Total cortisol is 90% bound to cortisol binding globulin (CBG). CBG varies between individuals, is elevated by oestrogens and reduced by acute illness or surgery. Low CBG levels may result in individuals apparently failing such tests, and receiving inappropriate steroid replacement. We hypothesised that correcting total cortisol for CB...